SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for HYPERION DEFI, INC. (HYPD) (CIK 0001682639) (HYPD) — Feb 11, 2019

HYPERION DEFI, INC. (HYPD) (CIK 0001682639)
Date: Feb. 11, 2019 · CIK: 0001682639 · Accession: 0000000000-19-001701

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-229365

Date
February 7, 2019
Author
Not clearly detected
Form
UPLOAD
Company
HYPERION DEFI, INC. (HYPD) (CIK 0001682639)

Letter

February 7, 2019 John Gandolfo Chief Financial Officer EYENOVIA, INC. 295 Madison Avenue, Suite 2400 New York, New York 10017 Re:EYENOVIA, INC. Registration Statement on Form S-3 Filed January 25, 2019 File No. 333-229365 Dear Mr. Gandolfo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Todd Schiffman at 202-551-3491 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text
February 7, 2019
John Gandolfo
Chief Financial Officer
EYENOVIA, INC.
295 Madison Avenue, Suite 2400
New York, New York 10017
Re:EYENOVIA, INC.
Registration Statement on Form S-3
Filed January 25, 2019
File No. 333-229365
Dear Mr. Gandolfo:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Todd Schiffman at 202-551-3491 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance